Viewing Study NCT01441193


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-02-06 @ 5:33 AM
Study NCT ID: NCT01441193
Status: TERMINATED
Last Update Posted: 2016-03-04
First Post: 2011-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)
Sponsor: Barbara Ensoli, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None preventive vaccine View
None Tat View
None Env View